Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Bioventus Inc. BVS
$1.21
На 18:03, 12 мая 2023
+106.61%
Потенциал через год
Ранг: 2
Ключевые показатели
-
Marketcap
59400212.00000000
-
week52high
10.02
-
week52low
0.80
-
Revenue
512117000
-
P/E TTM
0
-
Beta
0.28809400
-
EPS
-2.46000000
-
Last Dividend
0.00000000
-
Next Earnings Date
11 мая 2023 г. в 12:30
Описание компании
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Morgan Stanley | Overweight | Overweight | 12 авг 2022 г. |
| Morgan Stanley | Overweight | Overweight | 12 мая 2022 г. |
| Goldman Sachs | Neutral | Neutral | 21 мар 2022 г. |
| Craig-Hallum | Buy | 15 мар 2022 г. | |
| Morgan Stanley | Overweight | Overweight | 11 мар 2022 г. |
| Goldman Sachs | Neutral | Neutral | 07 сент 2022 г. |
| Morgan Stanley | Overweight | Overweight | 11 окт 2022 г. |
| Morgan Stanley | Overweight | Overweight | 10 ноя 2022 г. |
| JP Morgan | Underweight | Overweight | 09 ноя 2022 г. |
| Canaccord Genuity | Hold | Buy | 09 ноя 2022 г. |
| Craig-Hallum | Hold | Buy | 22 ноя 2022 г. |
| Goldman Sachs | Neutral | Neutral | 30 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Bartholdson John A. | A | 22727 | 22727 | 08 янв 2023 г. |
| HAWKINS WILLIAM A | A | 16648 | 16648 | 17 июн 2022 г. |
| NOHRA GUY P | A | 16648 | 16648 | 17 июн 2022 г. |
| Beyer Pat | A | 16648 | 16648 | 17 июн 2022 г. |
| Beyer Pat | A | 1930 | 965 | 17 июн 2022 г. |
| STALNECKER SUSAN M | A | 16648 | 16648 | 17 июн 2022 г. |
| Vizirgianakis Stavros G. | A | 16648 | 16648 | 17 июн 2022 г. |
| Vizirgianakis Stavros G. | A | 1930 | 965 | 17 июн 2022 г. |
| NEELS GUIDO J | A | 16648 | 16648 | 17 июн 2022 г. |
| SUTTER MARTIN P | A | 16648 | 16648 | 17 июн 2022 г. |
Новостная лента
Bioventus to Present at the 41st Annual J.P. Morgan Healthcare Conference
GlobeNewsWire
04 янв 2023 г. в 07:00
DURHAM, N.C., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS), a global leader in innovations for active healing, today announced that Ken Reali, chief executive officer, will present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023, at 5:15 p.m. PT (8:15 p.m. ET).
Bioventus Inc. (BVS) Q3 2022 Earnings Call Transcript
Seeking Alpha
11 ноя 2022 г. в 12:14
Bioventus Inc. (NASDAQ:BVS ) Q3 2022 Earnings Conference Call November 8, 2022 8:30 AM ET Company Participants Dave Crawford - VP of IR Ken Reali - CEO Mark Singleton - SVP and CFO Conference Call Participants Chase Knickerbocker - Craig-Hallum Capital Group Caitlin Cronin - Canaccord Genuity Drew Ranieri - Morgan Stanley Philip Coover - Goldman Sachs Rohin Patel - JPMorgan Operator Good day, and welcome to Bioventus Inc. Third Quarter 2022 Earnings Conference Call. All participants will be in a listen-only mode.
Why Shares of Bioventus Fell 14% on Wednesday
The Motley Fool
09 ноя 2022 г. в 18:18
The company's reduced guidance concerned investors.
Bioventus: Reiterating Buy Thesis Following Q2 Earnings
Seeking Alpha
08 сент 2022 г. в 10:48
Bioventus came in with another set of strong numbers in Q2. We reiterate the buy thesis on BVS and note there are numerous idiosyncratic risk premia on offer.
Bioventus Inc. (BVS) CEO Ken Reali on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
11 авг 2022 г. в 14:58
Bioventus Inc. (NASDAQ:BVS ) Q2 2022 Earnings Conference Call August 11, 2022 8:30 AM ET Company Participants Dave Crawford - VP of IR Ken Reali - CEO Mark Singleton - SVP and CFO Conference Call Participants Alex Nowak - Craig-Hallum Capital Group Robbie Marcus - JPMorgan Drew Ranieri - Morgan Stanley Phil Coover - Goldman Sachs Operator Good morning, and welcome to the Bioventus Incorporated Second Quarter 2022 Earnings Conference Call. All participants will be in listen-only mode.